Vicarious Surgical (NYSE:RBOT) PT decreased to $12.00

Indirect Surgery (NYSE:RBOT – Get Free Report) The target price was lowered by stock analysts at Piper Sandler from $30.00 to $12.00 in a report issued on Tuesday, Benzinga reports. The firm currently has a “neutral” rating on the stock. Piper Sandler’s price target indicates a potential upside of 129.01% from the stock’s previous close.

Separately, Morgan Stanley cut their price target on Vicarious Surgical from $18.00 to $10.00 and set an “equal weight” rating for the company in a report on Monday, July 15th.

Check out the latest stock analysis on RBOT

Indirect surgical trading up 0.6%

NYSE RBOT opened at $5.24 on Tuesday. The stock has a market cap of $30.77 million, a PE ratio of -0.46 and a beta of 1.13. Vicarious Surgical has a twelve month low of $4.27 and a twelve month high of $32.40. The stock has a fifty day simple moving average of $7.49 and a 200 day simple moving average of $9.27.

Hedge funds affect vicarious surgery

An institutional investor recently raised its position in shares of Vicarious Surgical. SRS Capital Advisors Inc. boosted its position in shares of Vicarious Surgical Inc (NYSE:RBOT – Free Report) by 215.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 87,905 shares of the company’s stock after acquiring an additional 60,000 shares during the quarter. SRS Capital Advisors Inc. owned 0.07% of Vicarious Surgical worth $32,000 at the end of the most recent quarter. 47.27% of shares are owned by institutional investors and hedge funds.

Vicarious Surgical Company Profile

(Get a free report)

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing the Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was founded in 2014 and is based in Waltham, Massachusetts.

See Also

Get news and reviews for Vicarious Surgical Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Vicarious Surgical and related companies with MarketBeat.com’s FREE daily email newsletter.